Therapeutic effects and potential risks of dacomitinib/dacomitinib

Dacomitinib/Dacomitinib (Dacomitinib) has a unique mechanism of action. It mainly exhibits its efficacy by inhibiting specific tyrosine kinase receptors (EGFR) on the surface of tumor cells. EGFR is a key protein that is closely linked to cell growth and differentiation. Its abnormal activation is often closely related to the development and spread of tumors. Dacomitinib can effectively block the activation process of EGFR, thereby inhibiting the growth and division of tumor cells and significantly reducing the risk of tumor spread and metastasis.

In clinical trials, dacomitinib has demonstrated significant therapeutic effects onNSCLC. It can significantly extend the patient's progression-free survival (PFS), significantly reduce the size of the tumor, and significantly improve the patient's quality of life. Compared with traditional chemotherapy regimens, dacomitinib performs particularly well in first-line treatment. A core study involving 452 patients with EGFR mutations showed that patients treated with dacomitinib had an average progression-free survival of approximately 15 months, while patients treated with gefitinib had an average of 9 months.

However, like many powerful drugs, dacomitinib comes with its own set of side effects. Common ones include diarrhea, rash, stomatitis, nail abnormalities, dry skin, loss of appetite, conjunctivitis, etc. In addition, patients may experience weight loss, hair loss, itching, elevated transaminase levels, and nausea. Thankfully, most of these side effects are mild to moderate and can be effectively alleviated with appropriate medication or adjustment of medication dosage.

However, it is worth noting that dacomitinib may also cause some serious side effects. Examples include severe diarrhea, interstitial lung disease, severe skin rashes, and loss of appetite. Therefore, when using dacomitinib, patients should pay close attention to their own body reactions and communicate with their doctors in a timely manner to ensure the safety and effectiveness of treatment.